healthcar
worker
wish
receiv
season
influenza
vaccin
spallanzani
institut
n
enrol
studi
approv
local
ethic
committe
particip
gave
written
inform
consent
baselin
characterist
studi
popul
report
tabl
blood
sampl
obtain
day
vaccin
vaccin
formul
fluarix
inactiv
purifi
split
influenza
vaccin
glaxosmithklin
verona
itali
antigen
composit
strain
anew
vaccin
dose
contain
ha
strain
phosphatebuff
salin
excipi
vaccin
administ
intramuscularli
madindarbycanin
kidney
mdck
cell
maintain
dulbecco
modifi
eagl
medium
dmem
contain
fetal
calf
serum
fc
mmoll
lglutamin
humidifi
atmospher
influenza
viru
use
strain
ahong
kindli
provid
paul
chan
viru
stock
use
challeng
antigen
hemagglutin
inhibit
hi
assay
propag
allanto
caviti
embryon
hen
egg
allanto
fluid
harvest
h
postinocul
clarifi
centrifug
viru
concentr
determin
ha
titrat
previous
describ
viru
store
use
viru
stock
use
microneutr
nt
cellmedi
immun
assay
propag
mdck
cell
cultur
supernat
collect
h
postinocul
tissu
cultur
infecti
dose
determin
titrat
mdck
cell
calcul
reed
muench
method
influenza
vaccin
uvinactiv
mdckderiv
influenza
viru
synthet
influenza
oligopeptid
use
antigen
cellmedi
immun
influenza
viru
inactiv
exposur
uv
light
min
complet
inactiv
uvexpos
viru
check
infect
mdck
monolay
undilut
prepar
backtitr
infect
day
postinfect
four
synthet
peptid
influenza
purchas
biodesign
intern
kennebunk
usa
sequenc
peptid
specif
aa
region
aa
aa
region
aa
crossmatch
ha
na
sequenc
peptid
bind
differ
allel
establish
accord
syfpeithi
site
wwwsyfpeithid
specif
peptid
bind
follow
hladr
allel
peptid
ntermin
region
bind
sever
hladr
allel
contrast
peptid
middl
region
appear
bind
hladr
allel
accord
allel
frequenc
local
popul
peptid
effici
present
studi
particip
cellmedi
respons
assess
detect
intracellular
interferongamma
product
effector
cell
antigenspecif
stimul
vitro
gener
effector
cell
memori
cell
peripher
blood
mononuclear
cell
pbmc
isol
densiti
gradient
centrifug
ficollhypaqu
pharmacia
biotech
uppsala
sweden
frozen
thaw
pbmc
cultur
medium
rpmi
fc
mmoll
lglutamin
stimul
influenza
vaccin
prepar
uvinactiv
influenza
moi
synthet
influenza
peptid
na
ha
peptideml
day
expand
addit
day
presenc
recombin
iuml
boehringermannheim
mannheim
germani
day
cell
restimul
antigen
presenc
immunoglobulin
k
clone
respect
becton
dickinson
mountain
view
ca
usa
brefeldina
sigma
st
loui
mo
usa
neg
control
mock
viru
prepar
obtain
uninfect
mdck
cell
irrelev
peptid
use
control
spontan
cytokin
product
cell
incub
includ
addit
frequenc
lymphocyt
donor
absenc
stimul
use
calcul
background
stimul
result
background
level
low
everi
experi
differ
observ
sampl
obtain
vaccin
frequenc
antigenspecif
cell
studi
particip
calcul
subtract
rel
background
level
cellmedi
immun
consid
posit
net
increas
although
retest
sampl
separ
occas
gave
reproduc
result
sampl
particip
test
simultan
reduc
test
variabl
monoclon
antibodi
coupl
phycoerythrin
pe
peridininchlorophyl
protein
percp
allophycocyanin
apc
combin
simultan
stain
studi
follow
use
percp
clone
clone
apc
clone
pe
clone
becton
dickinson
cell
stain
previous
describ
multiparametr
flow
cytometri
perform
use
facscanto
flow
cytomet
becton
dickinson
total
live
event
acquir
gate
small
viabl
lymphocyt
analyz
facsdiva
softwar
becton
dickinson
instrument
routin
calibr
accord
manufactur
instruct
nt
perform
accord
previous
describ
procedur
agreement
indic
world
health
organ
us
depart
health
human
servic
specif
serial
dilut
heatinactiv
min
human
sera
perform
dmem
without
fc
micropl
equal
volum
influenza
viru
ad
well
uninfectedcel
well
incub
test
serum
includ
plate
neg
control
h
incub
mixtur
transfer
mdck
cell
monolay
adsorb
h
wash
dmem
ad
plate
incub
day
nt
titer
assess
highest
serum
dilut
cytopath
effect
observ
light
microscop
inspect
serum
specimen
test
duplic
sampl
patient
assay
plate
time
result
score
person
blind
studi
particip
identif
test
result
reproduc
random
replic
assay
independ
occas
gave
consist
result
antibodi
titer
also
establish
hi
test
use
challeng
either
season
vaccin
eggderiv
influenza
prepar
hi
assay
perform
vbottom
plate
chicken
erythrocyt
describ
experi
live
highli
pathogen
avian
influenza
viru
conduct
use
biosafeti
level
contain
procedur
investig
requir
wear
appropri
mask
hepa
filter
frequenc
circul
antigenspecif
cell
healthi
donor
enrol
studi
analyz
flow
cytometri
use
intracellular
cytokin
stain
assay
vitro
expans
effector
cell
gener
effector
cell
memori
precursor
pbmc
challeng
antigen
vitro
day
expand
addit
day
presenc
effector
cell
character
abil
releas
cultur
overnight
presenc
antigen
cell
gate
analyz
cytokin
express
repres
experi
pbmc
recent
vaccin
healthi
donor
shown
figur
without
stimuli
cytokin
product
cell
detect
figur
panel
howev
stimul
season
influenza
vaccin
prepar
induc
product
effector
cell
figur
panel
b
cell
stimul
inactiv
influenza
viru
induc
tcell
respons
figur
panel
c
cell
final
cell
specif
pool
peptid
also
gener
donor
figur
panel
cell
product
observ
experiment
condit
extent
immun
season
influenza
vaccin
compar
healthi
donor
enrol
studi
nonhomogen
pattern
respons
detect
appendix
figur
vaccin
variat
frequenc
antigenspecif
cell
higher
baselin
arbitrarili
consid
signific
accord
threshold
increas
frequenc
cell
specif
vaccin
prepar
observ
vaccin
donor
donor
slight
increas
frequenc
vaccin
preparationspecif
cell
observ
donor
donor
mildtosignific
decreas
observ
remain
donor
n
shown
appendix
figur
panel
donor
detect
level
vaccin
cell
vaccin
six
donor
noteworthi
increas
baselin
cell
specif
subtyp
appendix
figur
panel
b
among
also
show
increas
frequenc
cell
specif
vaccin
prepar
donor
two
donor
donor
signific
increas
cell
specif
peptid
appendix
figur
panel
c
suggest
crosstyp
immun
may
directli
involv
hana
protein
furthermor
donor
donor
increas
frequenc
cell
even
unabl
respond
whole
viru
inde
person
also
observ
signific
decreas
cell
specif
vaccin
prepar
donor
specif
influenza
donor
specif
peptid
donor
donor
reduc
specif
respons
vaccin
prepar
show
higher
frequenc
specif
cell
compar
donor
vs
respect
p
similar
result
obtain
observ
influenza
viru
vs
respect
p
peptid
vs
respect
p
studi
particip
reactiv
inactiv
influenza
viru
well
peptid
pool
compos
peptid
consensu
sequenc
analyz
whether
reactiv
preferenti
direct
ha
na
shown
pbmc
repres
donor
figur
frequenc
effector
cell
appreci
challeng
inactiv
influenza
viru
figur
panel
b
cell
peptid
figur
panel
c
cell
respons
pbmc
donor
peptid
posit
wherea
respons
peptid
background
level
figur
panel
e
vs
cell
find
suggest
seem
main
target
cellmedi
crosstyp
immun
influenza
influenza
vaccin
strain
similar
pattern
observ
studi
particip
support
hypothesi
target
crosssubtyp
immun
could
actual
human
sera
donor
test
hi
activ
vaccin
influenza
prepar
neutral
activ
influenza
viru
individu
titer
report
figur
rise
ha
antibodi
titer
consid
noteworthi
vaccin
donor
show
noteworthi
rise
hi
titer
vaccin
prepar
indic
asterisk
figur
top
panel
black
bar
hi
titer
influenza
remain
undetect
level
season
vaccin
data
shown
rise
neutral
titer
baselin
observ
donor
figur
bottom
panel
asterisk
studi
particip
also
respond
season
vaccin
rise
hi
titer
vaccin
prepar
one
donor
show
high
titer
subtyp
nt
low
hi
titer
vaccin
uniqu
situat
studi
popul
howev
antibodi
influenza
vaccin
rais
vaccin
find
indic
season
vaccin
rais
neutral
immun
influenza
viru
show
exist
antibodydepend
crosstyp
immun
correl
influenzaspecif
cell
humor
respons
observ
suggest
type
antibodi
respons
mainli
tcell
independ
observ
influenzaspecif
cell
could
gener
longterm
cultur
vitro
easili
monitor
flow
cytometri
cell
approach
use
small
frequenc
cell
specif
subtyp
could
detect
sever
person
baselin
season
vaccin
administr
may
enhanc
frequenc
reactiv
cell
boost
crosssubtyp
cellular
immun
avian
influenza
also
observ
season
vaccin
rais
neutral
immun
subtyp
larg
number
donor
show
exist
antibodydepend
crosstyp
immun
thu
crossreact
immun
may
involv
cellular
andor
humor
respons
humor
respons
seem
independ
present
data
appear
target
crosstyp
cellular
immun
although
could
rule
involv
differ
ie
intern
antigen
possibl
target
immun
recognit
effector
cell
nevertheless
anim
model
cellular
immun
mainli
clt
target
intern
protein
ie
np
partli
respons
heterosubtyp
protect
induc
effici
inactiv
vaccin
use
live
viru
inactiv
split
vaccin
whole
inactiv
viru
ha
na
peptid
influenza
strain
data
discrimin
tcell
respons
extern
intern
antigen
case
vaccin
prepar
possibl
subtyp
respons
presum
respons
extern
antigen
result
peptid
point
specif
respons
na
result
obtain
whole
viru
obtain
peptid
complet
agreement
appendix
figur
find
explain
basi
substanti
differ
antigen
present
underli
whole
viru
peptid
moreov
observ
high
activ
specif
cell
baselin
associ
reduc
specif
respons
vaccin
suggest
stimul
preactiv
cell
high
dose
antigen
could
induc
tcell
anergi
consequ
loss
immun
respons
preliminari
evid
also
suggest
humor
crosstyp
immun
target
antigen
differ
ha
sera
person
show
signific
neutral
titer
influenza
recogn
insect
cell
express
ha
subtyp
shown
show
hi
activ
subtyp
may
possibl
also
target
humor
immun
addit
experi
western
blot
analysi
inhibit
na
activ
need
clarifi
point
anim
exposur
specif
subtyp
influenza
viru
also
induc
protect
immun
challeng
subtyp
heterosubtyp
crossprotect
immun
could
repres
key
mechan
face
limit
new
influenza
outbreak
hong
kong
influenza
outbreak
immun
respons
induc
influenza
viru
cell
antibodi
protect
chicken
lethal
influenza
moreov
adult
live
urban
area
unit
state
describ
influenzaspecif
memori
cell
recogn
epitop
influenza
viru
strain
deriv
swine
avian
speci
includ
influenza
strain
involv
hong
kong
outbreak
human
data
confirm
person
never
expos
subtyp
may
abl
gener
cellmedi
respons
hong
kong
influenza
isol
crosstyp
respons
may
natur
occur
probabl
consequ
exposur
season
influenza
strain
mice
antibodi
respons
contribut
control
influenza
viru
infect
although
antibodi
appear
facilit
recoveri
influenza
infect
gener
believ
b
cell
produc
neutral
isotypeswitch
influenzaspecif
antibodi
absenc
tcell
help
howev
data
clearli
demonstr
b
cell
also
produc
antiinfluenza
iga
igm
igg
respons
independ
helper
cell
bystand
respons
driven
activ
cell
specif
heterolog
antigen
may
contribut
socal
heterosubtyp
immun
howev
abil
influenza
viru
infect
promot
bcell
activ
differenti
shortliv
isotypeswitch
antibodysecret
cell
may
result
combin
bcell
receptor
hypercrosslink
engag
tolllik
receptor
product
cytokin
well
trigger
innat
immun
studi
cellular
humor
crossreact
immun
seem
target
antigen
ha
influenza
case
occur
mainli
young
peopl
find
may
explain
hypothes
older
peopl
although
previous
expos
subtyp
may
gain
protect
immun
previou
infect
sustain
circul
influenza
viru
strain
also
shown
immun
na
human
influenza
viru
crossreact
avian
na
viru
crossreact
protect
mice
infect
avian
influenza
viru
find
may
explain
hypothes
crossreact
immun
target
na
antigen
howev
whether
crossreact
antibodi
na
cell
would
protect
ill
death
especi
influenza
infect
known
studi
necessari
elucid
point
conclus
demonstr
vaccin
season
influenza
may
boost
crossreact
immun
unrel
strain
respons
deadli
infect
human
ie
avian
influenza
strain
ahong
data
togeth
previou
experiment
result
mice
studi
epidemiolog
report
indic
crosstyp
immun
consid
import
compon
immun
respons
novel
influenza
infect
